2 highly-rated ASX growth shares to buy

Here's why Kogan.com Ltd (ASX:KGN) and this ASX growth share have been tipped as the ones for investors to buy right now…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to boost your portfolio with some quality growth shares, then you might want to take a look at the ones listed below.

Here's why these quality ASX growth shares have been tipped as ones to buy right now:

Kogan.com Ltd (ASX: KGN)

The first ASX growth share to consider buying is Kogan. While this ecommerce company was already growing at a strong rate prior to the pandemic, its growth went up several gears after COVID accelerated the structural shift to online shopping.

This has underpinned an exceptionally strong first half performance. For example, Kogan recently released its half year update and revealed a 96% increase in gross sales over the prior corresponding period.

But perhaps even better, is that its margins have been expanding. As a result, Kogan's gross profit grew over 120% and its earnings before interest, tax, depreciation and amortisation (EBITDA) jumped over 140%.

While the worst of the pandemic is now behind us, the shift to online shopping still has a long way to go. This should mean Kogan benefits from this tailwind for some time to come.

Credit Suisse currently has an outperform rating and $21.08 price target on its shares.

ResMed Inc. (ASX: RMD)

A second ASX growth share to look at is ResMed. This sleep treatment-focused medical device company has been benefiting from tailwinds of its own over the last decade. The key one being the growing awareness of sleep disorders such as sleep apnoea.

This has underpinned very strong demand for ResMed's industry-leading portfolio of products. Positively, with the majority of sleep apnoea sufferers still undiagnosed, the company still has a huge runway for growth over the next few decades.

In addition to this, ResMed has been tipped as a company that will benefit greatly from a shift to home healthcare. This is thanks partly to some smart investments in the out of hospital space over the last few years. This includes its US$800 million acquisition of Brightree in 2016.

Credit Suisse is also a fan of ResMed. It currently has an outperform rating and $29.50 price target on the company's shares.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd. The Motley Fool Australia has recommended Kogan.com ltd and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 200 shares could rise 20% to 35%

These shares are being tipped to deliver market-beating returns by analysts.

Read more »

Keyboard button with the word sell on it.
Broker Notes

8 ASX All Ords stocks downgraded to sell ratings

Find out which shares are out of favour with the experts.

Read more »

Woman smiling whilst shopping in a clothing store.
Dividend Investing

Why this quality ASX 300 dividend stock is tipped to surge 54%

A leading fund manager forecasts significant outperformance from this quality ASX 300 dividend stock.

Read more »

A group of businesspeople clapping.
Broker Notes

Bell Potter names more of the best ASX 200 stocks to buy in June

These stocks could be best buys this month according to the broker.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Market News

Why Clarity, Coronado Global, Iperionx, and Lynas shares are roaring higher today

These shares are having a strong session on Thursday. Why are investors buying them?

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Opinions

The ASX 200 is approaching its all-time high. Here's why I'm not buying shares

I'm not seeing what the broader market is.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Qantas, Resimac, Tyro, and Soul Patts shares are falling today

These shares are having a tough session today. But why?

Read more »

Happy coal miner.
Share Gainers

Up 75% this week, why is this ASX All Ords stock rocketing again today?

Investors are piling into this ASX 300 stock on Wednesday. But why?

Read more »